Skip to main content
PD-L1 cutoff for pembrolizumab in mTNBC confirmed
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
PD-L1 cutoff for pembrolizumab in mTNBC confirmed
User login
Username
Password
Reset your password
Concept
Lead
score
Breast Cancer
1
1
Chemotherapy
0
0.89
Combination Chemotherapy
0
0.71
Triple Negative Breast Cancer
0
0.99
Breast
0
0.28
Cancer
0
0.28
Biologic Therapy
0
0.26
Toxicology
0
0.22
Tumor
0
0.11
Biomarker
0
0.06
California
0
0.06
Disease Recurrence
0
0.06
Hematology
0
0.06
Immunotherapy
0
0.06
Match
0
0.06
Medical Life
0
0.06
Neoadjuvant Therapy
0
0.06
Specialty
Lead
score
Hematology-Oncology
1
1
Internal Medicine
0
0.8
Ob/Gyn & Women's Health
0
0.9